Learn about conventional, complementary, and integrative therapies.
Dealing with treatment side effects? Learn about evidence-based therapies to alleviate your symptoms.
Click the orange button to the right to learn more.
I look at cardiac arrhythmias and their management differently. After reading about the short, long-term and late stage side effects that conventional therapies for managing my Afib can cause, I chose to pursue evidence-based non-conventional management therapies.
I was diagnosed with chemotherapy-induced cardiomyopathy in 2010. Afib was the main symptom that tipped me off to my cardiomyopathy.
According to research, the risk of stroke is for an average person my age (64) is 4.7%. When my heart flipped into chronic atrial fibrillation, in late 2010. According to the article linked below, my Afib increased my risk of stroke five-fold to about 24%.
I am not any sort of health professional much less a cardiologist. However, I’ve learned the hard way that conventional therapies often bring a host of side effects with them.
Of the many therapies that I pursue to reduce my risk of stroke, I have found few if any side effects. Omega-3 fatty acids, for example, reduce my risk of stroke while they provide many other health benefits.
Do exercise, fish oil, curcumin, acupuncture, etc. etc. reduce my risk of stroke as much as conventional therapies? I don’t know. All I know is that I have lived with chronic afib since 2010 and not suffered a stroke. I will write about it if I ever do have a stroke.
If you would like to learn more about non-conventional therapies for cardiac arrhythmia and its management email me at David.PeopleBeatingCancer@gmail.com
Thank you,
David Emerson
“Cardiac arrhythmias encompass a range of conditions characterized by abnormal heart rhythms, affecting millions globally and significantly contributing to morbidity and mortality.
This review provides a comprehensive analysis of the current practices and emerging therapies in managing cardiac arrhythmias, covering their
Cardiac arrhythmias encompass a range of conditions characterized by abnormal heart rhythms, affecting millions globally and significantly contributing to morbidity and mortality.
This review provides a comprehensive analysis of the current practices and emerging therapies in managing cardiac arrhythmias, covering their definition, classification, epidemiology, and the critical importance of effective management.
It explores the pathophysiology underlying various arrhythmias, including the mechanisms of arrhythmogenesis, such as re-entry, automaticity, and triggered activity.
The review details the latest diagnostic tools, including ECG, Holter monitoring, and electrophysiological studies, and discusses the clinical presentation of different arrhythmias, from supraventricular to ventricular types and bradyarrhythmias.
We examine current pharmacological and non-pharmacological treatment strategies, such as antiarrhythmic drugs, catheter ablation, and device therapy, highlighting their efficacy and limitations.
Furthermore, the review delves into emerging therapies, including advanced catheter ablation techniques, novel antiarrhythmic agents, gene therapy, and innovative device technologies like leadless pacemakers and subcutaneous implantable cardioverter-defibrillators (ICDs)…
Atrial fibrillation is the most common type, with an estimated 33 million individuals affected globally. The incidence of arrhythmias increases with age, and they are more common in individuals with underlying cardiovascular diseases such as hypertension, coronary artery disease, and heart failure [3]…
Effective management of cardiac arrhythmias is crucial due to their potential to cause significant morbidity and mortality [4]. Untreated arrhythmias can lead to severe complications, such as stroke, heart failure, and sudden cardiac death. For instance, atrial fibrillation is a major risk factor for stroke, increasing the risk by fivefold…
Cardiac arrhythmias can present with a wide range of symptoms, including palpitations, dizziness, fainting, chest discomfort, shortness of breath, fatigue, and anxiety. However, it is important to note that some arrhythmias can be asymptomatic and go unnoticed, with the irregular heartbeat detected during a routine physical examination or incidentally during diagnostic testing for other conditions [9]…
The most common type (of arrhythmia) is AF, marked by rapid and irregular electrical signals in the atria, leading to ineffective contractions. Patients with AF may experience palpitations, fatigue, shortness of breath, and an increased risk of stroke [13]. Management typically involves rate control using medications like beta-blockers, rhythm control with antiarrhythmic drugs, and anticoagulation therapy to prevent thromboembolic events…
Cardiac arrhythmias and their management is evolving rapidly, with several emerging therapies showing promise for improved outcomes. Among these, advances in catheter ablation techniques stand out as particularly significant. Catheter ablation has become a cornerstone treatment for various arrhythmias, particularly atrial fibrillation…